A higher possibility of finding viruses that cause Covid-19 was linked to patients who had taken the antiviral drugs.

There was also a 65% relative reduction in COVID-related medical visits (95% CI 24.4-83.8) with nirmatrelvir-ritonavir versus ...

COVID-19 antivirals, specifically, have become hard to access for some patients. Many requirements accompany the distribution of the drugs to patients, and for a good reason. Accessing antivirals ...

As many Brits are falling ill with seasonal illnesses a doctor revealed how to tell what is causing your cough ...

Nirmatrelvir-ritonavir effectively lowers hospitalization rates and long COVID symptoms in non-hospitalized, high-risk patients with mild to moderate COVID-19.

Symptoms of viruses like COVID and flu overlap with each other, but there are ways you can narrow it down to get the ...

Chatham-Kent health agencies urge the public to take advantage of the flu and COVID-19 vaccines and RSV (respiratory ...

COVID: Phase 1 pharmacokinetic profile supports the potential for ratutrelvir to be dosed as a once-a-day, single drug, ...

Illinois health officials receive flu and COVID-19 vaccinations, emphasizing the importance of immunization before the ...

Taking an antiviral medication for a year may prevent vision ... and whether the shingles vaccine affected COVID-19 diagnosis and severity among participants. Other principal study investigators ...

New research from Emory University reveals that nasal autoantibodies in COVID-19 patients may help predict disease severity, ...

Phase III Scorpio-PEP study results showed Shionogi & Co. Ltd.’s oral antiviral ensitrelvir fumaric acid (Xocova) reduced risk of symptomatic COVID-19 infection in subjects who were exposed to the ...